12:00 AM
Jun 29, 2009
 |  BC Week In Review  |  Company News  |  Deals

Covagen, Roche deal

Covagen will use its protein engineering technology to identify Fynomers that bind to undisclosed targets from...

Read the full 60 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >